Logo image of IVG.MI

IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis

Europe - BIT:IVG - NL0015000LU4 - Common Stock

18.445 EUR
+0.05 (+0.24%)
Last: 11/10/2025, 5:35:15 PM
Fundamental Rating

4

Taking everything into account, IVG scores 4 out of 10 in our fundamental rating. IVG was compared to 109 industry peers in the Machinery industry. IVG has a medium profitability rating, but doesn't score so well on its financial health evaluation. IVG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year IVG was profitable.
IVG had a positive operating cash flow in the past year.
Of the past 5 years IVG 4 years were profitable.
Each year in the past 5 years IVG had a positive operating cash flow.
IVG.MI Yearly Net Income VS EBIT VS OCF VS FCFIVG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

IVG has a Return On Assets of 1.73%. This is comparable to the rest of the industry: IVG outperforms 40.37% of its industry peers.
Looking at the Return On Equity, with a value of 12.39%, IVG is in the better half of the industry, outperforming 71.56% of the companies in the same industry.
IVG has a Return On Invested Capital (4.53%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for IVG is below the industry average of 8.90%.
The last Return On Invested Capital (4.53%) for IVG is above the 3 year average (3.91%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.73%
ROE 12.39%
ROIC 4.53%
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
IVG.MI Yearly ROA, ROE, ROICIVG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

The Profit Margin of IVG (2.17%) is worse than 60.55% of its industry peers.
IVG's Profit Margin has improved in the last couple of years.
The Operating Margin of IVG (5.00%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of IVG has grown nicely.
IVG has a Gross Margin of 16.49%. This is amonst the worse of the industry: IVG underperforms 88.07% of its industry peers.
IVG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5%
PM (TTM) 2.17%
GM 16.49%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
IVG.MI Yearly Profit, Operating, Gross MarginsIVG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IVG is destroying value.
IVG has less shares outstanding than it did 1 year ago.
The number of shares outstanding for IVG has been increased compared to 5 years ago.
IVG has a better debt/assets ratio than last year.
IVG.MI Yearly Shares OutstandingIVG.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
IVG.MI Yearly Total Debt VS Total AssetsIVG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

IVG has an Altman-Z score of 1.76. This is a bad value and indicates that IVG is not financially healthy and even has some risk of bankruptcy.
IVG has a Altman-Z score of 1.76. This is comparable to the rest of the industry: IVG outperforms 43.12% of its industry peers.
IVG has a debt to FCF ratio of 14.82. This is a negative value and a sign of low solvency as IVG would need 14.82 years to pay back of all of its debts.
The Debt to FCF ratio of IVG (14.82) is worse than 68.81% of its industry peers.
IVG has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
IVG's Debt to Equity ratio of 1.35 is on the low side compared to the rest of the industry. IVG is outperformed by 82.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 14.82
Altman-Z 1.76
ROIC/WACC0.64
WACC7.06%
IVG.MI Yearly LT Debt VS Equity VS FCFIVG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

IVG has a Current Ratio of 1.98. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
IVG has a Current ratio of 1.98. This is in the better half of the industry: IVG outperforms 77.98% of its industry peers.
IVG has a Quick Ratio of 1.40. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
IVG has a better Quick ratio (1.40) than 82.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.4
IVG.MI Yearly Current Assets VS Current LiabilitesIVG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

IVG shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.95%.
IVG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.82% yearly.
Looking at the last year, IVG shows a decrease in Revenue. The Revenue has decreased by -6.97% in the last year.
Measured over the past years, IVG shows a small growth in Revenue. The Revenue has been growing by 5.06% on average per year.
EPS 1Y (TTM)-5.95%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-38.1%
Revenue 1Y (TTM)-6.97%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-3.52%

3.2 Future

The Earnings Per Share is expected to grow by 10.81% on average over the next years. This is quite good.
IVG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.30% yearly.
EPS Next Y-12.5%
EPS Next 2Y6.41%
EPS Next 3Y9.46%
EPS Next 5Y10.81%
Revenue Next Year-2.33%
Revenue Next 2Y2.71%
Revenue Next 3Y3.58%
Revenue Next 5Y4.3%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
IVG.MI Yearly Revenue VS EstimatesIVG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
IVG.MI Yearly EPS VS EstimatesIVG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.67, the valuation of IVG can be described as very reasonable.
IVG's Price/Earnings ratio is rather cheap when compared to the industry. IVG is cheaper than 83.49% of the companies in the same industry.
IVG is valuated cheaply when we compare the Price/Earnings ratio to 26.06, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 7.83, which indicates a rather cheap valuation of IVG.
Based on the Price/Forward Earnings ratio, IVG is valued cheaply inside the industry as 89.91% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 32.73, IVG is valued rather cheaply.
Industry RankSector Rank
PE 11.67
Fwd PE 7.83
IVG.MI Price Earnings VS Forward Price EarningsIVG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IVG indicates a somewhat cheap valuation: IVG is cheaper than 79.82% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, IVG is valued a bit cheaper than the industry average as 70.64% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.51
EV/EBITDA 5.5
IVG.MI Per share dataIVG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.36
EPS Next 2Y6.41%
EPS Next 3Y9.46%

3

5. Dividend

5.1 Amount

IVG has a Yearly Dividend Yield of 1.79%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.60, IVG has a dividend in line with its industry peers.
IVG's Dividend Yield is slightly below the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.79%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

IVG pays out 27.33% of its income as dividend. This is a sustainable payout ratio.
DP27.33%
EPS Next 2Y6.41%
EPS Next 3Y9.46%
IVG.MI Yearly Income VS Free CF VS DividendIVG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M
IVG.MI Dividend Payout.IVG.MI Dividend Payout, showing the Payout Ratio.IVG.MI Dividend Payout.PayoutRetained Earnings

IVECO GROUP NV

BIT:IVG (11/10/2025, 5:35:15 PM)

18.445

+0.05 (+0.24%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-06 2025-11-06
Earnings (Next)02-05 2026-02-05/amc
Inst Owners39.4%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.00B
Revenue(TTM)14.81B
Net Income(TTM)322.00M
Analysts73.33
Price Target20.08 (8.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.79%
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP27.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-15.44%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)15.3%
Min EPS beat(4)-15.44%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)15.63%
EPS beat(12)8
Avg EPS beat(12)16.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-10.1%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-10.1%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.3%
EPS NY rev (1m)-2.91%
EPS NY rev (3m)-9.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.54%
Valuation
Industry RankSector Rank
PE 11.67
Fwd PE 7.83
P/S 0.34
P/FCF 12.51
P/OCF 3.88
P/B 1.92
P/tB 9.06
EV/EBITDA 5.5
EPS(TTM)1.58
EY8.57%
EPS(NY)2.36
Fwd EY12.77%
FCF(TTM)1.47
FCFY8%
OCF(TTM)4.75
OCFY25.77%
SpS54.61
BVpS9.58
TBVpS2.04
PEG (NY)N/A
PEG (5Y)0.36
Graham Number18.46
Profitability
Industry RankSector Rank
ROA 1.73%
ROE 12.39%
ROCE 6%
ROIC 4.53%
ROICexc 5.79%
ROICexgc 7.34%
OM 5%
PM (TTM) 2.17%
GM 16.49%
FCFM 2.7%
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexgc growth 3Y26.65%
ROICexgc growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 14.82
Debt/EBITDA 2.37
Cap/Depr 119.97%
Cap/Sales 6%
Interest Coverage 250
Cash Conversion 86.98%
Profit Quality 124.22%
Current Ratio 1.98
Quick Ratio 1.4
Altman-Z 1.76
F-Score6
WACC7.06%
ROIC/WACC0.64
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.95%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-38.1%
EPS Next Y-12.5%
EPS Next 2Y6.41%
EPS Next 3Y9.46%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-6.97%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-3.52%
Revenue Next Year-2.33%
Revenue Next 2Y2.71%
Revenue Next 3Y3.58%
Revenue Next 5Y4.3%
EBIT growth 1Y-21.25%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year74.95%
EBIT Next 3Y29.26%
EBIT Next 5YN/A
FCF growth 1Y-7.83%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-0.31%
OCF growth 3Y26.42%
OCF growth 5Y8.96%

IVECO GROUP NV / IVG.MI FAQ

Can you provide the ChartMill fundamental rating for IVECO GROUP NV?

ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.


Can you provide the valuation status for IVECO GROUP NV?

ChartMill assigns a valuation rating of 6 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Fairly Valued.


What is the profitability of IVG stock?

IVECO GROUP NV (IVG.MI) has a profitability rating of 5 / 10.


Can you provide the financial health for IVG stock?

The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.


What is the earnings growth outlook for IVECO GROUP NV?

The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to decline by -12.5% in the next year.